Gilead Sciences

(NASDAQ) GILD

Current Price$131.21

Market Cap$166.40B

Since IPO (1992)+30,566%

5 Year+138%

1 Year+37%

1 Month-7%

Gilead Sciences Financials at a Glance

Market Cap

$166.40B

Revenue (TTM)

$29.73B

Net Income (TTM)

$9.22B

EPS (TTM)

$6.78

P/E Ratio

19.77

Dividend

$3.19

Beta (Volatility)

0.42 (Low)

Dividend

$3.19

Beta (Volatility)

0.42 (Low)

Price

$131.21

Volume

427,838

Open

$130.12

Price

$131.21

Volume

427,838

Open

$130.12

Previous Close

$131.21

Daily Range

$128.98 - $133.33

52-Week Range

$96.19 - $157.29

Dividend

$3.19

Beta (Volatility)

0.42 (Low)

Price

$131.21

Volume

427,838

Open

$130.12

Previous Close

$131.21

Daily Range

$128.98 - $133.33

52-Week Range

$96.19 - $157.29

GILD News

The Largest Healthcare Companies by Market Cap in May 2026

Lyle DalyMay 8, 2026

A scientist looking through a microscope.

Best Biotech ETFs to Buy in 2026

Keith SpeightsApr 11, 2026

A biotech lab technician using multiple pipettes to load blood samples into test tubes.

How to Invest in iShares Biotechnology ETF (IBB)

Tony DongFeb 25, 2026

Biotech scientist working on a tablet with bio-related icons projected above it.

How to Invest in VanEck Biotech ETF (BBH)

Tony DongFeb 25, 2026

DNA with a section separated from the main part.

Page 1

GILD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gilead Sciences

Industry

Biotechnology

Sector

Health Care

Employees

17,000

CEO

Daniel P. O'Day, MBA

Website

www.gilead.com

Headquarters

Foster City, CA 94404, US

GILD Financials

Key Financial Metrics (TTM)

Gross Margin

81%

Operating Margin

38%

Net Income Margin

31%

Return on Equity

40%

Return on Capital

24%

Return on Assets

16%

Earnings Yield

5.06%

Dividend Yield

2.38%

Payout Ratio

32.48%

Stock Overview

Market Cap

$166.40B

Shares Outstanding

1.24B

Volume

427.84K

Avg. Volume

6.39M

Financials (TTM)

Gross Profit

$23.21B

Operating Income

$11.70B

EBITDA

$13.58B

Operating Cash Flow

$10.02B

Capital Expenditure

$563.00M

Free Cash Flow

$9.46B

Cash & ST Invst.

$10.61B

Total Debt

$24.59B

Gilead Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$6.96B

+4.4%

Gross Profit

$5.51B

+7.6%

Gross Margin

79.24%

N/A

Market Cap

$166.40B

N/A

Market Cap/Employee

$9.45M

N/A

Employees

17,600

N/A

Net Income

$2.02B

+53.7%

EBITDA

$2.35B

-9.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$7.31B

+142.9%

Accounts Receivable

$4.74B

+8.0%

Inventory

$4.34B

+146.7%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$1.31B

-53.2%

Return on Assets

16.38%

N/A

Return on Invested Capital

24.25%

N/A

Free Cash Flow

$2.43B

+46.8%

Operating Cash Flow

$2.54B

+44.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AMGNAmgen Inc.

AMGNAmgen Inc.$331.70+0.79%

PFEPfizer Inc.

PFEPfizer Inc.$25.67-3.06%

NVONovo Nordisk A/S

NVONovo Nordisk A/S$46.07+0.59%

DHRDanaher Corporation

DHRDanaher Corporation$171.16-2.56%

BMYBristol-Myers Squibb Company

BMYBristol-Myers Squibb Company$56.16-0.16%

SYKStryker Corporation

SYKStryker Corporation$285.47-2.98%

SNYSanofi

SNYSanofi$43.31+0.30%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

NOKNokia

NOKNokia$12.82+0.04%

POETPoet Technologies

POETPoet Technologies$10.95+0.14%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.35+0.01%

Questions About GILD

What is the current price of Gilead Sciences?

Gilead Sciences is trading at $131.21 per share.

What is the 52-week range for Gilead Sciences?

Over the past 52 weeks, Gilead Sciences has traded between $96.19 and $157.29.

How much debt does Gilead Sciences have?

As of the most recent reporting period, Gilead Sciences reported total debt of $22.17B.

How much cash does Gilead Sciences have on hand?

Gilead Sciences reported $7.63B in cash and cash equivalents in its most recent financial results.

What is Gilead Sciences’s dividend yield?

Gilead Sciences currently has a dividend yield of 2.38%.

Gilead Sciences

Gilead Sciences Financials at a Glance

GILD News

The Largest Healthcare Companies by Market Cap in May 2026

Best Biotech ETFs to Buy in 2026

How to Invest in iShares Biotechnology ETF (IBB)

How to Invest in VanEck Biotech ETF (BBH)

Top ETFs Tracking CRISPR Gene Editing for 2026

Should You Buy Gilead Sciences Before Feb. 10?

How to Buy Gilead Sciences Stock (GILD)

Why Gilead Sciences Stock Slipped Today

GILD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Gilead Sciences

GILD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Gilead Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GILD

What is the current price of Gilead Sciences?

What is the 52-week range for Gilead Sciences?

How much debt does Gilead Sciences have?

How much cash does Gilead Sciences have on hand?

What is Gilead Sciences’s dividend yield?

Premium Investing Services